Open access · CC-BY
via OpenAlex
What is the clinical evidence to support off-label rapamycin therapy in healthy adults?
Jacob M. Hands, Michael S. Lustgarten, Leigh A. Frame, Bradley Simon Rosen
Aging · 2025 · ▲ 1 citations
Deregulated nutrient-sensing
Rapamycin / mTOR inhibition
Human
Cohort study
Preclinical / animal
Review
Abstract
Low dose mTOR(definition)-inhibiting drug studied for extending healthspan and lifespan." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">rapamycin(definition) therapy has been proposed as a longevity candidate in healthy aging adults. We present a review of the evidence for low dose rapamycin and rapalog therapies in healthy human adults and model the findings of one cohort study using the PhenoAge model. Despite the preclinical evidence supporting the use of sirolimus to enhance mean and maximal lifespan, the data in humans have yet to establish that rapamycin, or its analogues, is a proven seno-therapeutic that can delay aging in healthy older adults. Rapamycin and rapalogs warrant further study with larger cohorts to better establish their contribution to human aging.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.18632/aging.206300
- Canonical
- link ↗
- Fetched
- 2026-10-12 MST
Cite this
APA
Hands, J.M., Lustgarten, M.S., Frame, L.A., & Rosen, B.S. (2025). What is the clinical evidence to support off-label rapamycin therapy in healthy adults?. <em>Aging</em>. https://doi.org/10.18632/aging.206300
Vancouver
Hands JM, Lustgarten MS, Frame LA, Rosen BS. What is the clinical evidence to support off-label rapamycin therapy in healthy adults?. Aging. 2025. doi:10.18632/aging.206300.
BibTeX
@article{jacob2025Whatis,
title = {What is the clinical evidence to support off-label rapamycin therapy in healthy adults?},
author = {Jacob M. Hands and Michael S. Lustgarten and Leigh A. Frame and Bradley Simon Rosen},
journal = {Aging},
year = {2025},
doi = {10.18632/aging.206300},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
AgelessRx 2020
Open access · US-GOV
Participatory Evaluation (of) Aging (With) Rapamycin (for) Longevity Study (PEARL): A Prospective, Double-Blind, Placebo-Controlled Trial for Rapamycin in Healthy Individuals Assessing Safety and Efficacy in Reducing Aging Effects
Proceedings of the National Academy of Sciences 2008
Open access · OA
FOXO3A genotype is strongly associated with human longevity
Irina Timofte 2026
Open access · US-GOV
Sirolimus in Older Adults- Randomized Trial Assessing the Improvement in Phenotypic/Functional Biomarkers of Aging
Aging 2014
Open access · OA
Rapamycin in preventive (very low) doses
Geriatrics and gerontology international/Geriatrics & gerontology international 2009
Citation only
Effect of rapamycin on lifespan in Drosophila
Proceedings of the National Academy of Sciences 2005
Preprint · OA